Global investment firm KKR has closed a $4bn fund dedicated to health care growth equity investment opportunities primarily in Europe and North America.
European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.
Germany has a new government - and a new Federal Minister of Health in Karl Lauterbach. HBI talks to two Germany-based sources who agree he is a politician embraced more by the public than his own party, and considers what his appointment might mean for the sector.
Life science properties that incorporate some laboratories in one form or another could be the next property boom says Piers Scrimshaw-Wright, who has just joined Knight Frank as Life Science and Innovation partner. So has anything been sold in Europe so far?
Australia's largest oncology provider Icon Group has been bought by EQT's infrastructure arm for AUS$2.4bn. Its CEO Mark Middleton tells HBI that the group now has its sights set on Europe.
Two strategics and a private equity player are bidding for Unilabs, the Pan-European, Mid East and LaTam lab and imaging group. So who is likely to win?
Global lab and imaging group Unilabs is in the second round of its sales process, HBI hears, with four bidders made up of private equity and strategic buyers.
Much of EMEA has shifted away from short three-year outsourcing contracts for imaging services. The UK, however, is lagging behind as its 3+2 year procurement laws are deterring the private sector from making major investments.
"This is the strongest M&A market I can remember," Hedley Goldberg, managing director at Rothschild & Co told hundreds of attendees at HBI 2021 as he talked about the IPO landscape and how post-COVID M&A is shaping up.
Increasing demand and rising costs are putting pressure on LatAm’s healthcare system. A regional session at HBI 2021 heard that out-of-pocket payments are on the increase, especially in Mexico.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
